14.01.2015 Views

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SOFT 2004 Meeting Abstracts - Society of Forensic Toxicologists

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

P9 <br />

DETERMINATION OF OXCARBAZEPINE AND ITS METABOLITES IN POSTMORTEM<br />

SPECIMENS INCLUDING HAIR BY MEANS OF LIQUID CHROMATOGRAPHY WITH MASS<br />

DETECTION (HPLC/APCIIMS) IN AN EPILEPTIC PATIENT AFTER A FATAL DRUG­<br />

POISONING<br />

Malgorzata Klys* and Sebastian Rojek<br />

Grzegorzecka str 16, Krakow, Malopolskie, 31-531, Poland<br />

One use <strong>of</strong>hair analysis in forensic toxicology is the documentation <strong>of</strong> prior drug administration. This is<br />

illustrated in a suicidal death <strong>of</strong> a 58-year-old epileptic patient who was treated with oxcarbazepine and<br />

probably with levomepromazine.<br />

The toxicological analysis carried out by HPLC/APCIIMS included also the hair (6cm length) besides <strong>of</strong><br />

postmortem blood and liver samples. The method was validated for oxcarbazepine (OXCBZ) and its two<br />

metabolites, 10-hydroxycarbazepine (CBZ-100H) and trans-diol-carbazepine (CBZ-diOH) in various<br />

biological matrices.<br />

Thetoxicological findings are as follows:<br />

Hair<br />

Autopsy<br />

Segment (2 Segment (2<br />

Segment (cm)<br />

cm)<br />

cm)<br />

I<br />

II<br />

III<br />

Blood Liver<br />

Concentration (I!Wg)<br />

Oxcarbazepine 3.9 10.4 13.0 0.79 n.d.<br />

18.4<br />

53.9<br />

105.9 13.96 15,28<br />

i CBZ-100H<br />

4.7*<br />

5.1 *<br />

8.1 * 17.6* -<br />

.0.5<br />

1.2<br />

3.0 0.23 n.d<br />

CBZ-diOH<br />

0.12*<br />

0.12* 0.23* 0.29*<br />

-<br />

Levomepromazine - - - 1.96 30,25<br />

*Relatlve concentration metabolite / prekursor<br />

n.d. - not detected<br />

The analysis <strong>of</strong> the postmortem blood indicated oxcarbazepine and its two main metabolites were present at<br />

therapeutic concentrations; levomepromazine was detected at a fatal concentration. In three 2-cm segments<br />

<strong>of</strong>hair,.oxcarbazepine and its two metabolites were detected; however, levomepromazine was not detected<br />

in this . specimen. A complex chemical-toxicological investigation confirmed the information that the<br />

decedent. was an epileptic patient and was treated with oxcarbazepine for at least 6 months before death. In<br />

addition, he took a toxic dose <strong>of</strong> levomepromazine in order to commit suicide. The analysis revealed<br />

differences between the' concentration levels <strong>of</strong> oxcarbazepine and its active metabolite CBZ-IOORin<br />

postmortem specimens and hair, suggesting different mechanisms <strong>of</strong> penetration <strong>of</strong> certain metabolites and<br />

their precursors into these materials.<br />

Keywords: oxcarbazepine, hair, LClAPCIIMS<br />

Page 344

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!